CAS 56943-06-7

Imidazo[2,1-b]thiazole, 6-(4-bromophenyl)-2,3,5,6-tetrahydro-, (6S)-

Description:

Imidazo[2,1-b]thiazole, 6-(4-bromophenyl)-2,3,5,6-tetrahydro-, (6S)-, with CAS number 56943-06-7, is a heterocyclic compound characterized by its fused imidazole and thiazole rings, which contribute to its biological activity and chemical properties. The presence of a 4-bromophenyl group enhances its lipophilicity and may influence its interaction with biological targets. This compound typically exhibits a chiral center at the 6-position, indicating that it can exist in different stereoisomeric forms, with the (6S)- configuration being of particular interest in pharmacological studies. Imidazo[2,1-b]thiazoles are known for their diverse biological activities, including antimicrobial, anti-inflammatory, and anticancer properties, making them valuable in medicinal chemistry. The tetrahydro structure suggests that the compound is saturated at certain positions, which can affect its reactivity and stability. Overall, this compound's unique structural features and potential biological applications make it a subject of interest in research and development within the pharmaceutical industry.

Formula: C₁₁H₁₁BrN₂S

T1001

CAS: 56943-06-7

T1001 is an antagonist of hypoxia-inducible factor-2α subunit (HIF-2α) which displaces residue M252 from inside the HIF-2α PAS-B pocket toward the ARNT subunit

Formula: C₁₁H₁₁BrN₂S

Color and Shape: Solid

Molecular weight: 283.19

Ref: TM-T69080